Mr. Levin's resignation comes after three days of disclosures of corruption in Pfizer's finance department, revealed by former Pfizer finance executive Mr. Ashok S. Idnani, on the Question Authority with Dr. Peter Rost blog.
Pfizer in the press release wrote that "Chief Financial Officer Alan Levin has resigned to pursue career opportunities outside Pfizer." Clearly, Mr. Levin doesn't appear to have a new job lined up just yet, which indicates this was not a voluntary separation from Pfizer.
And while it is impossible to know if the latest whistleblower revelations contributed to his exit, the timing should result in some serious questions about what precipitated the decision to get rid of the 45-year old CFO who'd only held the job for two years. At a minimum the timing means it is impossible to avoid that question, which Pfizer must have been well aware of.
Mr. Levin's "resignation" was announced on a weekend, after three days of sordid proof that Pfizer fired a finance executive who repeatedly warned Pfizer that the company hired detectives who paid bribes, used corporate spies, pretexting, and paid off competitor's employees to leak confidential information, and used other potentially illegal means of obtaining information for the company.
The documents the whistleblower provided show that high level Pfizer executives in India and the company's New York headquarters, including Jeff Kindler, had been made aware of the allegations before the whistleblower, who'd been with Pfizer for 28 years, was fired.
For full story of Pfizer's financial whistleblower see:
1. Pfizer Finance Executive Blows the Whistle - Part One
2. Pfizer Finance Executive Blows the Whistle – Part Two
3. Pfizer Finance Executive Blows the Whistle – Part Three